Letrozole in advanced breast cancer: the PO25 trial

por Mouridsen, Henning T.
Publicado 2007

Editorial

por Mouridsen, Henning T.
Publicado 2007

Letrozole in advanced breast cancer: the PO25 trial

por Mouridsen, Henning T.
Publicado 2007

Danish Breast Cancer Cooperative Group

por Christiansen, Peer, Ejlertsen, Bent, Jensen, Maj-Britt, Mouridsen, Henning
Publicado 2016

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group

por Nielsen, Ole S., Dombernowsky, Per, Mouridsen, Henning, Daugaard, Søren, Van Glabbeke, Martine, Kirkpatrick, Anne, Verweij, Jaap
Publicado 2000

Clinical and Histopathological Prognostic Factors in Chondrosarcomas

por Daugaard, Søren, Myhre-Jensen, Olaf, Schiødt, Torben, Jurik, Anne G., Keller, Johnny, Mouridsen, Henning T., Lund, Bjarne
Publicado 1997

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer

por Lykkesfeldt, Anne E, Henriksen, Katrine L, Rasmussen, Birgitte B, Sasano, Hironobu, Evans, Dean B, Møller, Susanne, Ejlertsen, Bent, Mouridsen, Henning T
Publicado 2009

The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients

por Jensen, Maj-Britt, Lænkholm, Anne-Vibeke, Balslev, Eva, Buckingham, Wesley, Ferree, Sean, Glavicic, Vesna, Dupont Jensen, Jeanette, Søegaard Knoop, Ann, Mouridsen, Henning T., Nielsen, Dorte, Nielsen, Torsten O., Ejlertsen, Bent
Publicado 2020